Patents by Inventor Thibaud Biadatti

Thibaud Biadatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of (3S)-N-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (S)-N_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions
    Publication number: 20090137569
    Abstract: Inflammatory skin pathologies/afflictions, e.g., eczema or psoriasis, are prevented and/or treated by administering to a subject in need of such treatment, a thus effective amount of at least one compound of following formula (I): in which R is a —CH3 radical or a CH2OH radical, or of a pharmaceutically acceptable salt, solvate or hydrate thereof.
    Type: Application
    Filed: September 17, 2008
    Publication date: May 28, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Marlene Schuppli
  • Administration of E-3[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid for preventing and/or treating inflammatory cutaneous pathologies/afflictions
    Publication number: 20090088460
    Abstract: Inflammatory cutaneous pathologies/afflictions, e.g., eczema or psoriasis, are prevented and/or treated by administering to a subject in need of such treatment, a thus effective amount of E-3-[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid of formula (I): or of a pharmaceutically acceptable salt, solvate or hydrate thereof.
    Type: Application
    Filed: September 17, 2008
    Publication date: April 2, 2009
    Applicant: GALDERMA RESEARCH &DEVELOPMENT
    Inventor: Thibaud Biadatti
  • Biphenyl compound selective agonists of gamma RAR receptors
    Publication number: 20090036536
    Abstract: Biphenyl compounds having the formula (I): are useful for preventing/treating pathologies linked to a deficiency of the activation of the RAR gamma receptor, e.g., for treating a pathology linked to a cell differentiation and/or proliferation disorder, for treating acne, for treating psoriasis.
    Type: Application
    Filed: June 16, 2008
    Publication date: February 5, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Etienne Thoreau
  • Biphenyl compound selective agonists of gamma RAR receptors
    Publication number: 20090023811
    Abstract: Biphenyl compounds having the formula (I): are useful for preventing/treating pathologies linked to a deficiency of the activation of the RAR gamma receptor, e.g., for treating a pathology linked to a cell differentiation and/or proliferation disorder, for treating acne, for treating psoriasis.
    Type: Application
    Filed: June 16, 2008
    Publication date: January 22, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Etienne Thoreau
  • Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
    Patent number: 7468457
    Abstract: Novel biaryl compounds having the structural formula (I): are useful in a variety of pharmaceutical applications, whether human or veterinary, and also in cosmetics.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: December 23, 2008
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Pascal Collette
  • Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
    Patent number: 7439396
    Abstract: Novel ligand compounds that activate RAR receptors have the following structural formula (I): and are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: October 21, 2008
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Anne-Pascale Luzy
  • Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20080213347
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Application
    Filed: October 30, 2007
    Publication date: September 4, 2008
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Patent number: 7348449
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: March 25, 2008
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
    Patent number: 7326803
    Abstract: Novel bicyclic compounds having the structural formula (I): are useful in a variety of pharmaceutical applications, whether human or veterinary, and also in cosmetics.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: February 5, 2008
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Pascal Collette
  • Novel ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof
    Publication number: 20080015246
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: June 25, 2007
    Publication date: January 17, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • Vitamin D analogues
    Patent number: 7312249
    Abstract: Novel biaromatic vitamin D analogues have the general formula (I): and are suited for a wide variety of pharmaceutical applications, whether in human or veterinary medicine, and also for cosmetic applications.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: December 25, 2007
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Etienne Thoreau, Johannes Voegel, Andre Jomard
  • Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20070117761
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Application
    Filed: June 8, 2006
    Publication date: May 24, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Jean-Marie Arlabosse
  • Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20070021473
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radical of formulae (a) to (c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: June 8, 2006
    Publication date: January 25, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Olivier Roye
  • Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
    Publication number: 20070004726
    Abstract: Novel ligand compounds that activate RAR receptors have the following structural formula (I): and are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: April 14, 2006
    Publication date: January 4, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Thibaud Biadatti, Anne-Pascale Luzy
  • Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20050234131
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (1): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Application
    Filed: April 28, 2005
    Publication date: October 20, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Novel vitamin D analogues
    Publication number: 20050182144
    Abstract: Novel biaromatic vitamin D analogues have the general formula (I): and are suited for a wide variety of pharmaceutical applications, whether in human or veterinary medicine, and also for cosmetic applications.
    Type: Application
    Filed: February 28, 2005
    Publication date: August 18, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Thibaud Biadatti, Etienne Thoreau, Johannes Voegel, Andre Jomard
  • Triaromatic vitamin D analogues
    Patent number: 6924400
    Abstract: The invention relates, as novel and useful industrial products, to triaromatic compounds, which are vitamin D analogues, of general formula (I): and also to a method for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, or alternatively in cosmetic compositions.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: August 2, 2005
    Assignee: Galderma Research & Development, SNC
    Inventors: Jean-Michel Bernardon, Thibaud Biadatti
  • Novel ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
    Publication number: 20050148670
    Abstract: Novel bicyclic compounds having the structural formula (I): are useful in a variety of pharmaceutical applications, whether human or veterinary, and also in cosmetics.
    Type: Application
    Filed: November 19, 2004
    Publication date: July 7, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Thibaud Biadatti, Pascal Collette
  • Novel ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
    Publication number: 20050131033
    Abstract: Novel biaryl compounds having the structural formula (I): are useful in a variety of pharmaceutical applications, whether human or veterinary, and also in cosmetics.
    Type: Application
    Filed: November 19, 2004
    Publication date: June 16, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Thibaud Biadatti, Pascal Collette
  • Vitamin D analogues
    Patent number: 6831106
    Abstract: The present invention relates to novel triaromatic compounds having the general formula (I): as well as to a method for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, in carcinology and in the field of autoimmune diseases and that of organ or tissue transplants in particular), or alternatively in cosmetic compositions.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: December 14, 2004
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Jean-Michel Bernardon, Thibaud Biadatti